Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Broqua

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
European Journal of Pharmacology|February 16, 1993
Subchronic treatment with anxiolytic doses of the 5-HT1A receptor agonist ipsapirone does not affect 5-HT2 receptor sensitivity in the ratV Baudrie, J De Vry, P Broqua, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 3, 1999
The discriminative stimulus properties of U50,488 and morphine are not shared by fedotozineP Broqua, J G Wettstein, M N Rocher, et al.
Neuroendocrinology|April 1, 1993
Are 5-HT1A autoreceptors involved in the inhibitory effect of ipsapirone on cold-elicited thyrotropin secretion?P Broqua, D Laude, M T Bluet-Pajot, et al.
Endocrinology|December 7, 2000
Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axesP D Raposinho, E Castillo, V d'Alleves, et al.
Molecular and Cellular Endocrinology|December 12, 2001
Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadismP D Raposinho, D D Pierroz, P Broqua, et al.
Neuroendocrinology|January 25, 2000
Stimulation of the gonadotropic axis by the neuropeptide Y receptor Y1 antagonist/Y4 agonist 1229U91 in the male ratP D Raposinho, P Broqua, A Hayward, et al.
Endocrinology|August 28, 1999
Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtypeP D Raposinho, P Broqua, D D Pierroz, et al.
Brain Research|June 10, 1996
Antinociceptive effects of neuropeptide Y and related peptides in miceP Broqua, J G Wettstein, M N Rocher, et al.
Journal of Medicinal Chemistry|July 21, 2001
GnRH antagonists: a new generation of long acting analogues incorporating p-ureido-phenylalanines at positions 5 and 6G Jiang, J Stalewski, R Galyean, et al.
The American Journal of Pathology|August 4, 2001
Clinical and experimental progression of a new model of human prostate cancer and therapeutic approachG de Pinieux, M E Legrier, F Poirson-Bichat, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
European Journal of Pharmacology|February 16, 1993
Subchronic treatment with anxiolytic doses of the 5-HT1A receptor agonist ipsapirone does not affect 5-HT2 receptor sensitivity in the ratV Baudrie, J De Vry, P Broqua, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 3, 1999
The discriminative stimulus properties of U50,488 and morphine are not shared by fedotozineP Broqua, J G Wettstein, M N Rocher, et al.
Neuroendocrinology|April 1, 1993
Are 5-HT1A autoreceptors involved in the inhibitory effect of ipsapirone on cold-elicited thyrotropin secretion?P Broqua, D Laude, M T Bluet-Pajot, et al.
Endocrinology|December 7, 2000
Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axesP D Raposinho, E Castillo, V d'Alleves, et al.
Molecular and Cellular Endocrinology|December 12, 2001
Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadismP D Raposinho, D D Pierroz, P Broqua, et al.
Neuroendocrinology|January 25, 2000
Stimulation of the gonadotropic axis by the neuropeptide Y receptor Y1 antagonist/Y4 agonist 1229U91 in the male ratP D Raposinho, P Broqua, A Hayward, et al.
Endocrinology|August 28, 1999
Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtypeP D Raposinho, P Broqua, D D Pierroz, et al.
Brain Research|June 10, 1996
Antinociceptive effects of neuropeptide Y and related peptides in miceP Broqua, J G Wettstein, M N Rocher, et al.
Journal of Medicinal Chemistry|July 21, 2001
GnRH antagonists: a new generation of long acting analogues incorporating p-ureido-phenylalanines at positions 5 and 6G Jiang, J Stalewski, R Galyean, et al.
The American Journal of Pathology|August 4, 2001
Clinical and experimental progression of a new model of human prostate cancer and therapeutic approachG de Pinieux, M E Legrier, F Poirson-Bichat, et al.
Pageof 2